SAAmplify-ɑSYN
Use
The SAAmplify-ɑSYN test is designed to detect misfolded α-synuclein in cerebrospinal fluid (CSF), which is critical for diagnosing neurodegenerative diseases. It is the only validated test with autopsy-confirmed accuracy, providing biological evidence to guide treatment decisions. This test offers clarity in diagnosing conditions such as Parkinson's, Lewy body dementia, and atypical Alzheimer's by revealing the underlying pathologies that symptoms alone cannot differentiate.
Special Instructions
Not provided.
Limitations
While the SAAmplify-ɑSYN test provides robust detection of α-synuclein pathologies, it is crucial to consider that neurodegenerative diseases often involve mixed pathologies. Therefore, additional tests and clinical assessments may be necessary to comprehensively diagnose and treat such conditions.
Methodology
Immunoassay (Other)
Biomarkers
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
Not provided
Minimum Volume
Not provided